Literature DB >> 22178424

Characteristics of TAV- and BAV-associated thoracic aortic aneurysms--smooth muscle cell biology, expression profiling, and histological analyses.

Stefan Blunder1, Barbara Messner, Thomas Aschacher, Iris Zeller, Adrian Türkcan, Dominik Wiedemann, Martin Andreas, Gert Blüschke, Günther Laufer, Thomas Schachner, David Bernhard.   

Abstract

OBJECTIVE: Past studies on the pathogenesis of thoracic aortic aneurysms have, by concentrating on histological and total tissue analyses, revealed several disease-relevant processes. Despite these studies, there is still a significant lack in the understanding of aneurysmal cell biology today. Hence, it was the goal of this study to assess differences between aneurysmal and healthy aortic smooth muscle cells (SMCs) on a broad - screening-like - basis, allowing us to formulate new hypotheses on the role of SMCs in thoracic aneurysm formation. METHODS AND
RESULTS: After histological characterization of a total of 16 samples from healthy aortas and thoracic aortic aneurysms (TAA) of patients with bicuspid (BAV) and tricuspid (TAV) aortic valves, we isolated aortic SMCs and subjected them to cell biological and gene expression analyses. The data obtained indicate that aneurysmal SMCs exert reduced proliferation and migration rates compared to controls. BAV TAA SMCs have significantly shorter telomeres, whereas TAV TAA SMCs showed a reduced metabolic activity. In BAV TAA SMCs osteopontin (OPN) expression was significantly elevated, and TAV TAA SMCs showed decreased expression of tissue inhibitor of metalloproteinase 3 (TIMP3).
CONCLUSION: Our study provides evidence that TAA-associated aortic wall disintegration in BAV and TAV TAAs shows similarities, but also significant differences. BAV and TAV TAAs differ with regard to medial elastic fiber mass and the occurrence of fibroblasts, SMC telomere length, metabolism, and gene expression. This study may form the basis for future in-depth analyses on the relevance of these findings in the pathophysiology of BAV and TAV TAAs.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22178424     DOI: 10.1016/j.atherosclerosis.2011.11.035

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  25 in total

1.  Aneurysm Development in Patients With Bicuspid Aortic Valve (BAV): Possible Connection to Repair Deficiency?

Authors:  Shohreh Maleki; Hanna M Björck; Valentina Paloschi; Sanela Kjellqvist; Lasse Folkersen; Veronica Jackson; Anders Franco-Cereceda; Per Eriksson
Journal:  Aorta (Stamford)       Date:  2013-06-01

2.  The genetic and molecular basis of bicuspid aortic valve associated thoracic aortopathy: a link to phenotype heterogeneity.

Authors:  Ratnasari Padang; Paul G Bannon; Richmond Jeremy; David R Richmond; Christopher Semsarian; Michael Vallely; Michael Wilson; Tristan D Yan
Journal:  Ann Cardiothorac Surg       Date:  2013-01

3.  Pulsed electromagnetic field improves postnatal neovascularization in response to hindlimb ischemia.

Authors:  Rui-Lin Li; Jing-Juan Huang; Yi-Qin Shi; An Hu; Zhao-Yang Lu; Liang Weng; Shen-Qi Wang; Yi-Peng Han; Lan Zhang; Chang-Ning Hao; Jun-Li Duan
Journal:  Am J Transl Res       Date:  2015-03-15       Impact factor: 4.060

4.  Evaluation of apoptotic molecular pathways for smooth muscle cells isolated from thoracic aortic aneurysms in response to oxidized sterols.

Authors:  Zelal Adiguzel; Nazli Arda; Omer Kacar; Muge Serhatli; Serpil Gezer Tas; Ahmet Tarik Baykal; Kemal Baysal; Ceyda Acilan
Journal:  Mol Biol Rep       Date:  2014-09-30       Impact factor: 2.316

5.  Angiogenesis effect of therapeutic ultrasound on ischemic hind limb in mice.

Authors:  Jing-Juan Huang; Yi-Qin Shi; Rui-Lin Li; An Hu; Hong-Sheng Zhou; Qian Cheng; Zheng Xu; Zhi-Ming Yang; Chang-Ning Hao; Jun-Li Duan
Journal:  Am J Transl Res       Date:  2014-11-22       Impact factor: 4.060

6.  Rescue of hypertension-related impairment of angiogenesis by therapeutic ultrasound.

Authors:  Zhao-Yang Lu; Rui-Lin Li; Hong-Sheng Zhou; Jing-Juan Huang; Jia Qi; Zhi-Xiao Su; Lan Zhang; Yue Li; Yi-Qin Shi; Chang-Ning Hao; Jun-Li Duan
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

7.  Regional Disruptions in Endothelial Nitric Oxide Pathway Associated With Bicuspid Aortic Valve.

Authors:  Mary P Kotlarczyk; Marie Billaud; Benjamin R Green; Jennifer C Hill; Sruti Shiva; Eric E Kelley; Julie A Phillippi; Thomas G Gleason
Journal:  Ann Thorac Surg       Date:  2016-06-07       Impact factor: 4.330

8.  The American Association for Thoracic Surgery consensus guidelines on bicuspid aortic valve-related aortopathy: Full online-only version.

Authors:  Michael A Borger; Paul W M Fedak; Elizabeth H Stephens; Thomas G Gleason; Evaldas Girdauskas; John S Ikonomidis; Ali Khoynezhad; Samuel C Siu; Subodh Verma; Michael D Hope; Duke E Cameron; Donald F Hammer; Joseph S Coselli; Marc R Moon; Thoralf M Sundt; Alex J Barker; Michael Markl; Alessandro Della Corte; Hector I Michelena; John A Elefteriades
Journal:  J Thorac Cardiovasc Surg       Date:  2018-08       Impact factor: 5.209

9.  Smooth muscle cells from abdominal aortic aneurysms are unique and can independently and synergistically degrade insoluble elastin.

Authors:  Nathan Airhart; Bernard H Brownstein; J Perren Cobb; William Schierding; Batool Arif; Terri L Ennis; Robert W Thompson; John A Curci
Journal:  J Vasc Surg       Date:  2013-09-27       Impact factor: 4.268

Review 10.  Aortic Dilatation in Patients With Bicuspid Aortic Valve.

Authors:  Jing Wang; Wenhui Deng; Qing Lv; Yuman Li; Tianshu Liu; Mingxing Xie
Journal:  Front Physiol       Date:  2021-07-06       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.